DNA
DNA (deoxyribonucleic acid) is the principal hereditary molecule in cellular organisms and many viruses.
DNA (deoxyribonucleic acid) is the principal hereditary molecule in cellular organisms and many viruses. It is a polymer of nucleotide units containing deoxyribose, phosphate, and one of four bases—adenine, thymine, cytosine, or guanine. Complementary base pairing between adenine–thymine and cytosine–guanine enables DNA to form a double-stranded helix and provides a mechanism for accurate replication. DNA sequences encode biological information used in the production and regulation of proteins and functional RNAs, while changes in DNA sequence or structure can influence cell behavior, disease susceptibility, and treatment response.
DNA is also an important biomedical target and experimental material. Its replication, topology, packaging, repair, and transcription can be altered by small molecules, proteins, and engineered nucleic-acid systems. Topoisomerase inhibitors, DNA-alkylating agents, and DNA-interacting compounds can produce strand stress, conformational changes, or DNA damage that contributes to apoptosis, cell-cycle arrest, and loss of cell viability. Conversely, cytosolic DNA can function as an innate immune signal through the cGAS–STING pathway. DNA sequence-specificity is additionally used in aptamer design, RNA:DNA hybrid detection, synthetic condensates, particle assembly, and high-throughput DNA engineering.
In research contexts, DNA is examined using methods including fluorescence, ultraviolet-visible spectroscopy, circular dichroism, Fourier-transform infrared spectroscopy (FTIR), mass spectrometry, and transmission electron microscopy. It is studied alongside RNA, microRNA, protein, extracellular vesicles, and biomarkers such as CD63 molecule and CD274 molecule. These applications span breast cancer and other malignancies, infectious disease, nucleic-acid quality control, and the design of programmable materials. Analytical performance may be assessed through sensitivity and detection limit, whereas therapeutic studies commonly evaluate cytotoxicity, IC50, reactive oxygen species, apoptosis, and cell-cycle arrest.
Rebuilt from PubMed 10 Sept 2026 · no new papers today
Where the papers sit
8 papers study dna directly. Those 8 are one subject: DNA Applications and Biology. The cluster spans DNA interactions in cancer, vaccine contamination assessment, DNA-coated materials, bacterial engineering and antiparasitic topoisomerase inhibitors. No single biological question or shared direction links these applications. No way of splitting those 8 scores better than chance.
Recent Findings on DNA
Topoisomerase-associated antiparasitic activity: A study of topoisomerase II inhibitors in Giardia intestinalis trophozoites used in silico analysis to examine whether the compounds could interact with GiTopo2 and DNA strands. The work places DNA within a topoisomerase-targeted mechanism in which interference with DNA topology may contribute to antiparasitic activity 42498008Jul.
DNA sensing during cancer immunotherapy: A nanoplatform combining a natural COX-2 inhibitor with paclitaxel and manganese-containing components was investigated for triple-negative breast cancer (TNBC) immunotherapy. The reported mechanism linked pyroptosis-derived cytosolic DNA to cGAS–STING signaling; Mn²⁺ was described as potentiating this pathway, increasing type I interferon production and innate immune activation 42102776May. This connects DNA damage or release during cancer treatment with immune processes including antigen presentation and immune-mediated tumor control.
Harmaline–DNA interactions: The potential anticancer effects of harmaline in TNBC were examined in relation to its interaction with DNA. UV-visible spectroscopy, fluorescence, circular dichroism, FTIR, and KI-quenching analyses indicated a mixed binding mode involving both intercalation and groove-associated interactions. These interactions were reported to produce conformational alterations in the DNA helix and were evaluated in the context of apoptosis, anti-metastatic activity, and computational analysis 42640499Aug.
In vivo DNA engineering: SCRIVENER—described as “sequential conjugation and recombination for in vivo elongation of nucleotides with low errors”—was introduced as a DNA assembly platform based on mating bacteria. The platform was reported to streamline and scale DNA engineering, extending DNA research beyond its role as a cellular information molecule to its use as an experimentally programmable substrate. Escherichia coli is among the bacterial systems relevant to this type of DNA engineering context 42385708Jul.
Sequence-programmed DNA materials: DNA-coated particles were studied as building blocks for functional and finite-sized assemblies. Their behavior can be programmed through orthogonal interactions generated by sequence-specific hybridization between DNA strands, allowing control over particle association and organization. This work extends DNA applications into soft materials and self-assembly rather than therapeutic DNA targeting 42530495Jul.
Assessment of residual DNA in mRNA vaccines: A critical analysis addressed a prior report by Achs and colleagues that claimed no excessive residual DNA in COVID-19 mRNA vaccines. The report under discussion characterized the earlier assessment as relying on four orthogonal approaches, with the present publication focused on systematic methodological flaws in DNA-contamination assessment 42599093Aug. The context illustrates the importance of assay design, analytical sensitivity, and detection limits when measuring DNA in RNA-based pharmaceutical products.
DNA-alkylating payload in an antibody–drug conjugate: Final phase 1 cohort-expansion results for vobramitamab duocarmazine described an antibody–drug conjugate directed against B7 homolog 3 (B7-H3). Its cytotoxic payload was identified as a duocarmycin-based DNA-alkylating agent, linking antibody-mediated delivery to chemical modification of tumor-cell DNA 42487497Jul. The study therefore represents DNA as the intracellular target of a targeted anticancer payload rather than as the extracellular recognition target of the antibody.
DNA-based synthetic condensates and liposomes: DNA-based synthetic condensates were used to organize and trigger the release of liposomes. Varying anchor density allowed liposomes to be localized on the surface or within the interior of condensates, while DNA base-pairing selectivity enabled targeting of individual internal domains in multiphasic condensates 42429747Jul. This demonstrates how programmable DNA hybridization can control spatial organization in synthetic biomolecular systems.
Relationship to broader research themes: Taken together, these publications extend the supplied literature clusters on long-fragment nucleic-acid detection, topoisomerase-targeted cancer cell death, and innate immune activation with pyroptosis. They also open applications not captured fully by those clusters, particularly DNA-based particle assembly, synthetic condensate organization, and scalable bacterial DNA construction. Across these areas, DNA is investigated both as a biological target associated with cytotoxicity, apoptosis, and cell-cycle arrest and as a programmable material used with RNA, aptamers, extracellular vesicles, paclitaxel, fluorouracil, fluorescence-based assays, flow cytometry, mass spectrometry, and transmission electron microscopy.
Written from 8 PubMed abstracts, each one cited by PMID above. Published: 2026-09-02. Drafted by language models from published abstracts; not medical advice.